NCT00002565 arm group acdb1c7ce4d4f40c5caaddbffa76e2f1 [clinicaltrials_resource:NCT00002565/arm-group/acdb1c7ce4d4f40c5caaddbffa76e2f1]
CHOP regimen [clinicaltrials_resource:2fa025b7102a4da2ba433318ff674252]doxorubicin hydrochloride [clinicaltrials_resource:3ed5c28f40b0cd9f5b1db36c0cd32d2e]vincristine sulfate [clinicaltrials_resource:6ca167850a60c238ac072f414e497251]prednisone [clinicaltrials_resource:6eed07744a1e45dc79c227704dddc97e]cyclophosphamide [clinicaltrials_resource:fe7aa7a8c520804ddb380e7e28d00231]Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00002565 arm group acdb1c7ce4d4f40c5caaddbffa76e2f1 [clinicaltrials_resource:NCT00002565/arm-group/acdb1c7ce4d4f40c5caaddbffa76e2f1]
Bio2RDF identifier
NCT00002565/arm-group/acdb1c7ce4d4f40c5caaddbffa76e2f1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... db1c7ce4d4f40c5caaddbffa76e2f1
description [clinicaltrials_vocabulary:description]
4-Drug Combination Chemotherap ...... prednisone): CTX/DOX/VCR/PRED.
identifier
clinicaltrials_resource:NCT00002565/arm-group/acdb1c7ce4d4f40c5caaddbffa76e2f1
title
NCT00002565 arm group acdb1c7ce4d4f40c5caaddbffa76e2f1
@en
type
label
NCT00002565 arm group acdb1c7c ...... b1c7ce4d4f40c5caaddbffa76e2f1]
@en